Cannabis was just removed from the same category as heroin in the U.S.
The historic federal reclassification of cannabis to Schedule III marks a major turning point, promising to bypass decades of research restrictions and help scientists fully study its true medical potential.
For more than 55 years, the federal government categorized marijuana alongside highly restricted substances like heroin and LSD under Schedule I.
By shifting cannabis to Schedule III, the government has recognized its potential medical applications, breaking a decades-long bottleneck for the scientific community. While the reclassification does not legalize recreational use or allow interstate commerce under federal law, it lifts the intense bureaucratic and regulatory hurdles that have historically stifled clinical research.
Researchers will now find it significantly easier to conduct clinical trials, study diverse formulations, and obtain cannabis products that accurately reflect what is sold in state-regulated markets.
As more states establish medical marijuana programs, this reform represents a vital step toward gathering hard scientific data. Rather than declaring cannabis completely harmless, scientists emphasize that this policy shift is about finding clear answers regarding the risks, benefits, and optimal clinical uses of the plant.
source: NBC News. Cannabis reclassification could ‘open the floodgates’ for research, scientists say.
About the Author
